Exendin (9-39) April 13, 2017 Exendin (9-39) Trade Name Orphan Indication Noninsulinoma pancreatogenous hypoglycaemia syndrome EU Market Approval EU EU Designation Date 2016-10-14 00:00:00 Sponsor Eiger Biopharmaceuticals Europe Limited
